Position in PCVX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,638
+$2 QoQ
Shares Held
97
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#280
of 329 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MCF Advisors LLC holds $1,699,982 across 27 Biotechnology names. PCVX ranks #19 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,136 | $486,523 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
451 | $224,025 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
27,241 | $154,728 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
2,187 | $119,278 | |
| 5 | MNKD |
Mannkind Corp
|
25,110 | $106,968 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
2,400 | $93,624 | |
| 7 | EYPT |
EyePoint, Inc.
|
6,420 | $91,806 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
415 | $77,721 |
All Filings in PCVX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,638 | 97 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,636 | 97 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,475 | 97 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,493 | 97 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,153 | 97 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $3,662 | 97 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $8,186 | 100 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $11,427 | 100 | Shares | Sole | 2024-10-24 | |
| No filing history on record for this holder in this stock. | ||||||